Loading page content…
Loading page content…
This is a business case to fund a Radiotherapy Quality Assurance (RTTQA) programme provided by the QA team hosted at Mount Vernon Cancer Centre. The team will lead the pre-assessment quality assurance of up to 30 radiotherapy providers to enable local delivery of for renal Stereotactic Ablative Radiotherapy (SABR) cancer and Stereotactic radiosurgery (SRS) for essential tremor, both of which are new clinical indications recently supported for routine commissioning via Clinical Priorities Advisory Group (CPAG) prioritisation following the policy development process. The team hosted at Mount Vernon Cancer Centre (MVCC) hosted at East and North Herts NHS Trust, is the sole provider of this service in the UK. QA plays a fundamental part to clinical trial participation in the UK and is led by the RTTQA team. The experienced team has led the QA process previously as part of the NHS England specialised commissioning SABR commissioning through evaluation programme from 2015-2018, SRS RTTQA following the reprocurement of the SRS/SRT service in 2024, and completion of a multiyear programme of SABR rollout for several clinical indications including primary lung cancer and simple oligometastat
BidWriter drafts your responses from your company profile, scores them against the marking scheme, and tracks your whole pipeline. Free to start — no card needed.
Start free →